Our Entrepreneurs

Christopher Whitfield

Batswadi Pharmaceuticals

Christopher Whitfield Christopher Whitfield
“I saw an opportunity to transform the pharmaceutical industry in South Africa.”
Country
South Africa
Industry
Healthcare
Year selected
2007
Website

Company Snapshot

Christopher founded Batswadi Pharmaceuticals in October 2005 as a specialist healthcare company focusing on four core business areas: pharmaceuticals, diagnostics, research and development, and consumer health. After jump-starting the company by leading a management buy-out of Eli Lilly’s insulin portfolio in South Africa, Christopher has quickly built Batswadi into a diversified company with significant potential. As the only black-empowered (majority-owned by historically disadvantaged South Africans) pharmaceutical company in South Africa, Batswadi is a rising star.

Endeavor and Batswadi Pharmaceuticals

Christopher is actively receiving guidance in the areas of fundraising and branding. In addition to local support, he has benefited from the Global eMBA and G-Lab programs, and an Immersion Tour.

Christopher has been on the Endeavor South Africa board since 2008, and serves as a local panelist.

From the Entrepreneurship Blog

Events

Endeavor Hosts 53rd ISP: 29 High-Impact Entrepreneurs from 9 Countries Join the Endeavor Network

April 10th, 2014 — by admin

Florianópolis, Brazil – April 10, 2014 – Endeavor selected 29 high-impact entrepreneurs leading 16 companies in 9 countries at its 53rd International Selection Panel. Endeavor now supports 917 Hi…

Read more

In the news

Mexico's Intellego Named a World Economic Forum Global Growth Company in Latin America

April 14th, 2014 — by admin

Founded by Endeavor Entrepreneurs Felipe Labbé and Vicente Perez, Mexico-based Intellego was recently named by the World Economic Forum as a Global Growth Company (GGC) of 2014, which highlights 1…

Read more

Contact us

Press center

Community

Newsletter Sign Up